Creative Planning Iovance Biotherapeutics, Inc. Transaction History
Creative Planning
- $93.6 Billion
- Q2 2024
A detailed history of Creative Planning transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Creative Planning holds 71,593 shares of IOVA stock, worth $672,258. This represents 0.0% of its overall portfolio holdings.
Number of Shares
71,593
Previous 77,063
7.1%
Holding current value
$672,258
Previous $1.14 Million
49.74%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding IOVA
# of Institutions
323Shares Held
239MCall Options Held
1.27MPut Options Held
1.68M-
Vanguard Group Inc Valley Forge, PA26MShares$244 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY25.9MShares$244 Million6.02% of portfolio
-
Mhr Fund Management LLC New York, NY24MShares$225 Million28.39% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$199 Million0.0% of portfolio
-
State Street Corp Boston, MA12.6MShares$119 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $1.48B
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...